Why Drugmaker Eli Lilly Is Partnering With ChatGPT Maker OpenAI

Key TakeawaysEli Lilly is partnering with ChatGPT maker OpenAI to use artificial intelligence to develop new treatments to combat drug-resistant diseases.The companies called drug-resistant diseases one of the "top public health and development threats" in global health.The partnership joins Eli Lilly's other efforts in this area, including investments of millions into funds that promote the creation of antibiotics. Eli Lilly (LLY) said it is partnering with ChatGPT maker OpenAI to use artificial intelligen ...